Study to Investigate the Safety and Efficacy of Ranibizumab in Patients With Choroidal Neovascularisation Due to Causes Other Than Age Related Macular Degeneration
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Ranibizumab
Related studies linked through entity extraction aliases.
Ranibizumab and Bevacizumab for Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Ranibizumab With or Without Laser in Comparison to Laser in Branch Retinal Vein Occlusion
- Status
- COMPLETED
- Phase
- PHASE3
Lucentis KAV Study
- Status
- COMPLETED
- Phase
- PHASE3
The LIMO Study, Lucentis for Treatment of Uveitic Patients With Refractory Cystoid Macular Oedema
- Status
- COMPLETED
- Phase
- PHASE2
FUSION Regimen: Combined Pro re Nata and Fixed Regimen Ranibizumab in Exudative Age-related Macular Degeneration
- Status
- COMPLETED
- Phase
- PHASE4
Safety and Efficacy Study of Dexamethasone Versus Ranibizumab in Patients With Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab Versus Ranibizumab for the Treatment of Diabetic Macular Edema
- Status
- UNKNOWN
- Phase
- PHASE2
Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema
- Status
- COMPLETED
- Phase
- PHASE2
Ranibizumab in Residual Diabetic Macular Edema Following Previous Anti-VEGF Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Study EvAluating Genotypes While Using Lucentis 2
- Status
- COMPLETED
- Phase
- PHASE4
Wet AMD Recurrence Rate in Patients Stable on Three Month Ranibizumab Dosing
- Status
- COMPLETED
- Phase
- PHASE4
Hemodilution Versus Ranibizumab in Early-onset Central Retinal Vein Occlusion
- Status
- COMPLETED
- Phase
- PHASE4
Study to Assess the Effectiveness of Existing Anti vascUlar Endothelial Growth Factor (Anti VEGF) in Patients With Wet Age-related Macular Degeneration (wAMD) (AURA)
- Status
- COMPLETED
- Phase
- N/A
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy Study of Ozurdex® Compared to Lucentis® in Patients With Branch Retinal Vein Occlusion
- Status
- COMPLETED
- Phase
- PHASE4
Ranibizumab for the Management of Recurrent Nosebleeds in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
- Status
- WITHDRAWN
- Phase
- PHASE1
Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With Ranibizumab
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Evaluation of AGN-150998 in Exudative Age-related Macular Degeneration (AMD)
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)
- Status
- COMPLETED
- Phase
- PHASE3